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protein that plays a key role in cellular lipid metabolism, preventing the accumulation of lipids
that contribute to the initiation and progression of atherosclerosis. Tiaozhi Tongmai Granules
are a Chinese herbal compound that is capable of treating atherosclerosis. This study was de-
signed to explore the potential pharmacological mechanism by which Tiaozhi Tongmai Gran-
ules protect against atherosclerosis.
Methods: Forty-ninemale New Zealand rabbits were randomly divided into seven groups: normal
control group, normal diet; model groups 1 and 2: balloon injury and high-fat diet for 6 or 12
weeks; statin groups 1 and 2: balloon injury and high-fat diet plus atorvastatin for 6 or 12 weeks;
and Chinese herb groups 1 and 2: balloon injury and high-fat diet plus Tiaozhi Tongmai Granulesssette transporter A1; ALP, alkaline phosphatase; ALT, alanine transaminase; CCA, common carotid
l carotid artery; HDL-C, high density lipoprotein cholesterol; ICA, internal carotid artery; IEF, internal
protein cholesterol; OD, optical density; TA, thoracic aortae; TC, total cholesterol; TCM, traditional
T, weight.
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Tiaozhi Tongmai Granules 39for 6 or12 weeks. The granules were administered at a dose of 1.14 g/kg/d, with atorvastatin
(1.14 mg/kg/d) serving as positive control. Serum lipid profiles and liver function indices were
measured. Atherogenesis was viewed after H&E staining and quantified by thickened intimal area
percentage and maximal intimal thickness percentage. The ABCA1 protein expression in athero-
sclerotic plaque macrophages of the common carotid arteries (CCA), thoracic aortae (TA), and
liver tissues were observed by immunohistochemical staining and evaluated using mean optical
density (OD) value in macrophages and ABCA1-positive hepatocyte number.
Results: Compared with model group 1 at week 6, Chinese herb group 1 and statin group 1 dis-
played significant reductions in total cholesterol (TC) (PZ 0.027, 0.012) and low-density lipopro-
tein cholesterol (LDL-C) (PZ 0.039, 0.028) levels, as well as marked increases in ABCA1-positive
hepatocyte numbers (Pall<0.001), and only statin group 1 displayed amarkedly reducedmaximal
intimal thickness percentage in the CCA (PZ 0.018). Compared with model group 2 at week 12,
Chinese herb group 2 and statin group 2 all presented significant reductions in TC (PZ 0.011,
0.003), LDL-C (PZ 0.017, 0.010) and thickened intimal area percentage in the CCA (PZ 0.001,
0.022), as well as prominent increases in the ABCA1 OD value of both the CCA (P Z 0.001,
0.039) and TA (PZ 0.001, 0.025) and positive hepatocyte number (P all <0.001). Chinese herb
group 2 had a markedly reduced maximal intimal thickness percentage compared with model
group 2 (PZ 0.006) and a higher positive hepatocytes number than statin group 2 (PZ 0.001).
Conclusions: Tiaozhi Tongmai Granules appear to have an anti-atherogenic effect that is most
likely mediated by simultaneously upregulating the protein expression of ABCA1 in rabbit athero-
sclerotic plaque macrophages and in the liver.
ª 2014 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/3.0/).Introduction
Atherosclerosis, the common pathological basis of
numerous cardio-cerebro-vascular diseases, begins with the
accumulation of blood lipids in the subendothelial space of
blood vessels,1 which induces the recruitment of circulating
monocytes that give rise to macrophages and the uptake of
accumulated lipids by macrophages. Initially, this uptake
process is regarded as a self-defense mechanism by which
blood vessel lipotoxicity is prevented. However, the process
is not always a positive one overall without the aid of a
robust lipid efflux function to maintain normal cellular lipid
metabolism when macrophages take up lipids.
ATP-binding cassette transporter A1 (ABCA1) is an inte-
gral membrane protein that uses ATP as a source of energy
to promote efflux of cholesterol and phospholipids from
cells.2 The elimination of excess cholesterol from macro-
phages is mediated by ABCA1,3 which ensures a normal
number and size of lipid droplets within cells, thus pre-
venting the formation of macrophage-derived foam cells.
Statins, 3-hydroxy-3-methyl-glutaryl coenzyme A reduc-
tase inhibitors, can lower blood lipid level by suppressing
biosynthesis of cholesterol, thus playing a key role in pro-
tecting against atherosclerosis. Several studies have
confirmed statin versatility beyond their cholesterol-lowing
properties. Statins can upregulate the mRNA level of ABCA1
in various cells,4e7 including culturedmacrophages,8,9 where
cholesterol loading is needed.10 Conversely, the depletion of
cellular cholesterol can reduce ABCA1 mRNA after statin
treatment,11,12 though the underlying mechanisms are not
yet fully clear. However, ABCA1 mRNA level does not repre-
sent the true activities of the protein it encodes due to awide
range of post-transcriptional regulation.13 Although statinsinduced large levels of plaque regression for the first time in
the study of coronary atheroma by intravascular ultrasound:
effect of rosuvastatin versus atorvastatin (SATURN) trial,
statin treatment still results in nearly one-third of patients
continuing to suffer plaque progression.14 Thus, statin ther-
apy may not be perfect.
The present study aimed to determine the exact thera-
peutic effects of a Chinese herbal compound called Tiaozhi
Tongmai Granules in an atherosclerotic animal model. This
compound may have a potential role in the treatment of
atherosclerosis in humans. Therefore, our animal study may
elucidate the potential pharmacological mechanisms by
which the compound protects against atherosclerosis from
the perspective of lipid metabolism as based on traditional
Chinese medicine (TCM) theories.Materials and methods
Animals and diets
A total of 49 healthy male New Zealand rabbits aged 3e4
months and with initial weight of approximately 3.0 kg each
were purchased from Beijing JMY Laboratory Animal
Breeding Co. Ltd. [permit number SCXK (Beijing) 2010-0001].
High-fat diets composed of cholesterol 1%, lard 3%, yolk
powder 10%, and normal diet 86%were obtained from Beijing
HFK Bioscience Co. Ltd. [permit number SCXK (Beijing) 2009-
0008]. The present studywas conducted strictly according to
recommendations set forth in theChineseGuide for the Care
and Use of Laboratory Animals. The Committee on the Ethics
of Animal Experiments of Beijing University of Chinese
Medicine approved this study (approval number 37570).
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Tiaozhi Tongmai Granules, based on a TCM empirical for-
mula, is comprised of seven ingredients: Radix Astragali
20 g, Radix Angelicae Sinensis 15 g, Semen Cassiae 30 g,
Rhizoma Alismatis 12 g, Fructus Crataegi 30 g, Lumbricus
15 g, and Radix Notoginseng 6 g. The herbal granule com-
pound was prepared according to standard procedure.15
The seven herbs were decocted together twice in water,
and the decoction was filtered. The filtrate was collected,
concentrated into the appropriate amount and spray-dried.
Adjunct ingredients were added and after blending evenly,
the granules were prepared with each dose ultimately
weighing 20 gram. The granules were provided by the Bei-
jing University of Chinese Medicine Third Affiliated Hospi-
tal. Atorvastatin calcium tablets (Pfizer Pharmaceuticals,
Approval No. H20051408, Batch No. 1237304) were provided
by the China-Japan Friendship Hospital, Beijing.
Quality control of Tiaozhi Tongmai Granules
The monarch herb, the leading ingredient in Tiaozhi Tong-
mai Granules, is Radix Astragali, in which astragaloside IV
acts as one of the main bioactive components, and thus is
the marker of quality control for the herb.16,17 The content
of astragaloside IV, detected using previously reported
method,18,19 in the prepared granules was 0.046%, which
met the requirements (0.040%) of the Pharmacopoeia of
People’s Republic of China, 2010 Edition.20 In addition, we
performed a component identification test of another main
ingredient in the granules, Semen Cassiae, according to a
previously described method21 and confirmed that the
granules contained chrysophanol and aurantio-obtusin, the
two representative markers of Semen Cassiae prescribed by
the Pharmacopoeia. The aforementioned components are
described in more details in Supplemental files 1 and 2. All
herbs were reliably provided by the Beijing University of
Chinese Medicine Third Affiliated Hospital.
Animal groups
After being fed adaptively normal diets for 1 week, all
rabbits were randomly divided into 7 groups (7 rabbits per
group). The normal control group was fed with a normal
diet for 2 weeks and sacrificed. The remaining six groups
were all fed with high-fat diets for 2 weeks and then
received a balloon injury procedure on the left common
carotid arteries. In these six groups, model groups 1 and 2
continued to receive high-fat diets for 6 and 12 weeks
before sacrifice, respectively. Statin groups 1 and 2
received atorvastatin therapy plus high-fat diets for 6 and
12 weeks, respectively, before sacrifice. Chinese herb
groups 1 and 2 received Tiaozhi Tongmai Granules plus high-
fat diets for 6 and 12 weeks, respectively, before sacrifice.
Establishment of atherosclerotic model in rabbits
ABCA1 overexpression in normal C57BL/6 mice on a proa-
therogenic diet may play an anti-atherogenic role and
significantly reduce aortic atherosclerosis. However, apoE
gene knock-out (apoE-KO) mice overexpression of ABCA1(i.e., ABCA1 transgene, ABCA1-Tg) has produced conflicting
data. Singaraja et al.22 reported a marked reduction in
atherosclerotic lesions in ABCA1-TgapoE-KO mice,
whereas Joyce et al.23 demonstrated a significant increase
in atherosclerosis. Reasons behind these phenomena are
not clear. Most likely the proatherogenic effect induced by
the absence of the apoE gene may counteract the protec-
tive effect of ABCA1, leading to difficulty and uncertainty in
the interpretation of the results. To avoid interference
related to the gene knock-out, we chose New Zealand
rabbits with a normal genetic background. Proatherogenic
serum lipid profiles on a high-fat diet are achieved easily in
these animals, and when combined with a balloon injury
operation, the formation of atherosclerotic plaques can be
accelerated.
The balloon injury procedure was performed as follows:
fasting rabbits were anesthetized using 25% urethane (4 ml/
kg) intravenously combined with Sumianxin (0.05 ml/kg)
intramuscularly and placed on the back (face-up). Systemic
heparinization was performed by intravenously injecting
heparin sodium at a dosage of 200 IU/kg. After the cervical
skin was depilated, sterilized, and incised along the median
line, the left common carotid artery (CCA), internal carotid
artery (ICA) and external carotid artery (ECA) were freed
and exposed by blunt dissection at the level of the superior
border of the thyroid cartilage. The distal ECA was ligated,
and the CCA and ICA were occluded temporarily with two
vascular clamps. At the site 0.3 cm away from the carotid
bifurcation in the left ECA, a tiny v-shaped opening was cut
with a pair of ophthalmic microscopic scissors. A heparin-
ized hollow catheter conveying device was then inserted
into the CCA from that opening. After releasing the vascular
clamp on the CCA, a catheter with a tiny inflatable balloon
(2.0 mm  15 mm or 2.5 mm  15 mm) at its tip, a balloon
catheter (SeQuent, B. Braun Medical, Inc., USA), was
threaded through the conveying device into the CCA. When
the tip was placed at the proximal end of the CCA, the
balloon was inflated to a low atmospheric pressure
(2.0e3.5 atm) with a manual pressure pump. The inflated
balloon was then retracted at an appropriate speed to the
distal end of the CCA and deflated to produce a vascular
injury. After repeating the injury procedure thrice, the
balloon catheter was withdrawn, followed by ligation of the
ECA at the position between the opening and carotid
bifurcation. Finally, the remaining vascular clamp was
removed to restore blood flow in the left CCA-ICA passage.
The wound was sutured and bandaged.Drug intervention and animal administration
Atorvastatin was administered at a clinical equivalent
dosage of 1.14 mg per kilogram per day (equivalent to
20 mg per 70 kilogram adult per day), and Tiaozhi Tong-
mai Granules were administered at a clinical equivalent
dosage of 1.14 g per kilogram per day (equivalent to one
dose of 20 gram per 70 kilogram adult per day) all via
intragastric injection. The two types of drugs were dis-
solved in an appropriate amount of distilled water to
ensure the drug delivery volume was maintained at 4 ml
per kilogram per day. Model groups were intragastrically
administered the same volume of distilled water alone
Tiaozhi Tongmai Granules 41without any drugs. All rabbits remained in individual
cages, with temperature-controlled air-conditioning in 12
hour cycles of light and dark. Animals were each given ad
libitum access to distilled water and a high-fat diet of
120 g per day.
Specimen collection
At the end of experiment, blood samples were collected via
the right common carotid arteries and centrifuged for
10 min at 3000 rpm at 4 C to obtain serum. Levels of serum
total cholesterol (TC), triglyceride (TG), low-density lipo-
protein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), alanine transaminase (ALT) and alka-
line phosphatase (ALP) were measured with a Hitachi 7600
biochemistry autoanalyzer (Japan). After sacrificing the
animals by air embolization, 1 cm long vascular tissues were
cut from the left CCA at its bifurcation and from the
thoracic aorta at the start of the descending aorta. The left
middle lobe of the liver was selected for collection of tissue
blocks, and a 1 cm  1 cm  0.5 cm volume was considered
suitable. After rinsing gently with normal saline, the tissue
was fixed in 10% neutral buffered formalin and embedded in
paraffin. Four micron thick serial sections were used.
Morphological analysis
Sections were stained with Harris hematoxylin and eosin
(H&E) using Leica ST 5020 Multistainer (Germany). Images
were viewed and captured with an Olympus BX53 micro-
scope attached to the Olympus cellSens imaging software
platform (Japan). For vascular tissues, the measurement of
(1) the thickened intimal area (i.e., plaque area) and (2)
the maximal intimal thickness and the circumference of
internal elastic lamina (IEF), by which the circular area
surrounded by IEF and its radius can be calculated, were
performed using Image-Pro Plus software (version 6.0,
Media Cybernetics, USA). Finally, the thickened intimal
area per circular area surrounded by IEF (%) and the
maximal intimal thickness per radius of circular area sur-
rounded by IEF (%) were quantified to evaluate the degree
of plaque progression by taking the average of 3 sections
spaced 20 microns apart.
Immunohistochemical staining
Tissue sections were mounted on positively charged slides
(CITOGLAS, 188105W), deparaffinized and rehydrated.
Heat-induced antigen retrieval was performed using a
pressure cooker in sodium citrate buffer (10 mM sodium
citrate in distilled water, pH 6.0) for 3 minutes as soon as
the cooker had reached full pressure. Sections on the slides
were treated with 3% H2O2 in PBS for 15 min to inactivate
the endogenous peroxidase, followed by incubation in 10%
normal goat serum in PBS for 30 min at room temperature
to block non-specific protein-protein interaction. The pri-
mary mouse monoclonal anti-ABCA1 antibody (Abcam,
ab18180) was applied to the slides diluted to the concen-
tration of 10 mg/ml (for blood vessels) or 5 mg/ml (for liver)
in antibody diluent (Invitrogen, 00-3118) and then the
ready-to-use polymer-HRP anti-mouse secondary antibody(ZSGB-BIO, PV-9002) was used according to the manufac-
turer’s protocol. Afterward, the slides were stained with
DAB solution (ZSGB-BIO, ZLI-9018) for the appropriate time
control under a microscope and finally dehydrated,
cleared, and mounted.
For vascular tissues, the plaque area and the integrated
optical density of positively expressed ABCA1 protein within
theplaqueweremeasuredusing Image-ProPlus software. The
ratio of the latter to the former was the mean optical density
that was needed. For the liver, all hepatocytes and the he-
patocytes expressing ABCA1 protein, designated positive
cells, within the individual hepatic lobules were counted, and
the positive cells per all hepatocytes (%) value was then
calculated. The quantifications were performed by taking the
average of 3 sections (for the blood vessels) and 5 indepen-
dent fields of view in 3 sections (for the liver).
Statistical analysis
SPSS statistics software (version 18.0, SPSS Inc., USA) was
used for statistical analysis. All data were presented as
mean  standard deviation (SD). The comparison of the
mean values between two groups was evaluated with a two-
tailed Student’s t-test, and multiple group comparisons
were performed with one-way analysis of variance (ANOVA)
followed by the LSD or S-N-K method. P-values less than
0.05 were considered significant.
Results
General conditions and serum biomarkers
Two rabbits died of diarrhea, 1 of flatulence, and 3 of drugs
entering the lungs during intragastric injection. The
remaining animals remained alive and well. The surgical
wounds healed without incident. Serum biomarkers and
body weight of rabbits in all groups are listed in Table 1.
Among serum lipid biomarkers, TC level decreased signifi-
cantly in statin group 1 and Chinese herb group 1
compared with model group 1 at week 6 (F Z 11.987,
P Z 0.012 and P Z 0.027) as well as in statin group 2 and
Chinese herb group 2 compared with model group 2 at the
week 12, respectively (PZ 0.003 and PZ 0.011). Similarly,
LDL-C level also presented significant reductions in statin
group 1 (F Z 10.421, P Z 0.028) and Chinese herb group 1
(P Z 0.039) compared with model group 1 as well as in
statin group 2 (P Z 0.010) and Chinese herb group 2
(P Z 0.017) compared with model group 2. However, TG
and HDL-C levels failed to display any significant differ-
ences among all groups. Between the two drug groups, no
significant difference in TC and LDL-C was observed at
either time points. Liver function indices, such as ALT and
ALP, were non-statistically (F Z 0.732 and F Z 0.358, P
all > 0.05) different between the model group and two drug
groups at either time points.
Evaluation of atherosclerotic plaque
In the present study, the size of atherosclerotic plaques
evaluated was represented by two types of percentages:
Table 1 Serum lipid profiles, liver function, and body weight of rabbits among groups.
Group n TC
(mmol/L)
TG
(mmol/L)
LDL-C
(mmol/L)
HCL-C
(mmol/L)
ALT (U/L) ALP (U/L) WT (kg)
Normal 7 1.05  0.23 0.78  0.46 0.34  0.06 3.26  0.23 23.00  1.41 49.00  8.49 3.00  0.15
Model 1 7 23.08  3.07 0.90  0.58 24.20  2.49 4.19  1.38 22.00  4.66 69.15  9.28 3.32  0.19
Statin 1 6 12.10  6.47* 1.12  1.35 13.32  4.12* 3.74  2.83 36.50  6.36 68.75  6.55 3.28  0.13
Chinese
herb 1
6 13.63  4.95* 0.66  0.57 14.03  4.92* 5.08  1.42 32.00  5.64 65.60  5.20 3.10  0.24
Model 2 6 32.03  4.21 0.83  0.76 33.15  2.45 7.22  0.95 37.29  6.02 58.25  8.52 4.35  0.78
Statin 2 6 16.95  4.31** 0.98  0.48 19.16  6.24** 6.83  0.78 50.50  7.78 66.00  5.66 4.25  0.87
Chinese
herb 2
5 19.45  7.42** 0.89  0.63 20.30  5.87** 6.88  0.66 40.75  3.42 54.00  7.07 4.30  0.81
Data are the presented as the mean  SD. *P < 0.05, vs. model group 1; **P < 0.05, vs. model group 2.
42 Q. Sun et al.the thickened intimal area per circular area surrounded by
IEF and the maximal intimal thickness per radius of circular
area surrounded by IEF. For the CCA, at week 6 after
balloon injury, the two percentage values were the largest
in model group 1 and lower in the two drug groups, with
only the maximal intimal thickness percentage in statin
group 1 decreasing significantly (P Z 0.018, Fig. 1B)
compared with model group 1. At week 12 after balloon
injury, the thickened intimal area percentage increased to
the top in model group 2 and decreased significantly in
statin group 2 and Chinese herb group 2 (F Z 21.146,
P Z 0.022 and P Z 0.001) compared with model group 2
(Fig. 1A), of which Chinese herb group 2 presented a slightly
greater reduction than statin group 2, although the trend
was not significant (P Z 0.546). The maximal intimal
thickness percentage decreased significantly in Chinese
herb group 2 (FZ 12.461, PZ 0.006) but not in statin group
2 (P Z 0.351) compared with model group 2 (Fig. 1B).
As thoracic aortae (TA) had just formed a minimal lesion
after 6 weeks due to the only impact of a high level of blood
lipids, the present study only evaluated the more signifi-
cant lesion formed after 12 weeks. At this point in time,
neither of the two percentages for the TA in model group 2
was comparable to those of the CCA after 6 weeks in model
group 1. The two drug groups both displayed reducingFigure 1 Sizes of atherosclerotic plaques in the CCA and TA. (A) R
in the CCA at weeks 6 and 12 and the TA at week 12. (B) The ratio of
by IEF in the CCA at both time points and the TA at week 12. *P <percentages compared with model group 2, yet these re-
ductions were not significant (P all >0.05).ABCA1 expression in macrophages within
atherosclerotic plaques of common carotid arteries
At week 6 post-procedure, ABAC1 protein was mostly
expressed focally in the superficial layer of plaques in the
model group 1 (Fig. 2A e d, g). In statin group 1, the protein
had an increasing region of expression still at the superficial
layer of plaques, primarily with a banded structure (Fig. 2Ae
e, h). There was a broader distribution of ABCA1 protein in
Chinese herb group1, someofwhich even reached themiddle
layer of plaques in addition to the superficial layer (Fig. 2Ae
f, i). At the cellular level, ABCA1 protein was expressed not
only in the plasma membrane but also within the cytoplasm
of individual macrophages within plaques. In statin group 1,
ABCA1 protein was commonly expressed in the peripheral
region of the cytoplasmnear the plasmamembrane (Fig. 2Ae
h). In Chinese herb group 1, the protein filled nearly the
whole cell in addition to its membrana expression, which was
most likely due to the absence of large lipid droplets in the
cytoplasm (Fig. 2Ae i). These results suggest that ABCA1 has
a broader cytoplasmic localization for achieving its shuttlingatio of thickened intimal area to circular area surrounded by IEF
maximal intimal thickness to radius of circular area surrounded
0.05, vs. model groups.
Figure 2 ABCA1 protein expression patterns in common carotid arteries. (A) H&E (aec, jel, s) and ABCA1 immunohistochemical
staining (dei, mer, t) of the left common carotid artery sections in all groups. Images g, h, i, p, q, and r (barsZ 50 mm) are higher
magnifications of images d, e, f, m, n, and o (barsZ 100 mm), respectively. Solid boxes within images h, i, p, q, and r show patterns
of ABCA1 expression in individual intimal macrophages. Dotted line in each image represents internal elastic lamina. (B) Evaluation
of mean optical density (OD) of ABCA1 protein in macrophages within plaques of common carotid arteries among groups. *P < 0.05,
vs. model group 2.
Tiaozhi Tongmai Granules 43between the plasma membrane and the cytoplasm, although
it acts as an integrated membrane protein and performs its
function mainly in the plasma membrane.
After 12 weeks, model group 2 presented an unsharp
distribution of ABCA1 protein in plaques and faint mem-
branal and cytoplasmic expression in individual macro-
phages (Fig. 2A e m, p). In statin group 2, ABCA1 was
expressed strongly in the middle layer of plaques and
weakly in the superficial layer. Protein expression was
maintained in the plasma membrane of macrophages and in
the peripheral region of cytoplasm near the plasma mem-
brane (Fig. 2A e n, q). In Chinese herb group 2, ABCA1 was
expressed vigorously in all layers of plaques and distributed
in larger areas within the macrophage cytoplasm in addition
to their membranal expression (Fig. 2A e o, r) compared
with the other two groups.
In regard to the mean optical density (OD) value of
ABCA1 protein within plaques (Fig. 2B), statin group 1 and
Chinese herb group 1 displayed increases in this value
compared with model group 1 after 6 weeks, but thesedifferences were non-significant (FZ 4.850, PZ 0.121 and
P Z 0.054). Compared with model group 2 after 12 weeks,
the OD of ABCA1 increased significantly in statin group 2
and Chinese herb group 2 (P Z 0.039 and P Z 0.001).
Chinese herb group 2 displayed a slightly greater increase
trend than statin group 2, although this trend was not sig-
nificant (P Z 0.156).
ABCA1 expression in macrophages within thoracic
aortae atherosclerotic plaques
ABCA1 protein was located mostly in the middle plaque
layer and was at low levels in the superficial and deep layer
in model group 2 after 12 weeks (Fig. 3A e a, g). In com-
parison, statin group 2 displayed an even distribution of
ABCA1 protein in the superficial and even the deep layer of
plaques in addition to the middle layer (Fig. 3A e b, h). The
expression of ABCA1 in Chinese herb group 2 extended to all
layers (Fig. 3A e c, i). The OD of ABCA1 within plaques was
significantly increased in statin group 2 and Chinese herb
Figure 3 ABCA1 protein expression patterns in thoracic aortae. (A) H&E (d, e, f, j) and ABCA1 immunohistochemical staining
(aec, gei, k) of thoracic aortae sections. Images a plus g, b plus h, and c plus i (bars Z 100 mm) are higher magnifications dotted
boxes in images d, e, and f (bars Z 400 mm), respectively. Dotted line in each image represents internal elastic lamina. (B)
Evaluation of mean optical density (OD) of ABCA1 protein in macrophages within plaques of thoracic aortae among groups.
*P < 0.05, vs. model group 2.
44 Q. Sun et al.group 2 (F Z 10.853, P Z 0.025 and P Z 0.001) compared
with model group 2 (Fig. 3B), but there was no significant
difference between the two drug groups (P Z 0.211).
ABCA1 expression in the liver
Hepatocytes that expressed ABCA1 protein in their plasma
membrane (hereafter called positive cells) were locatedmostly in the peripheral region within the hepatic lobule
and rarely in the centrilobular area adjacent to the central
vein (CV) in model group 1 after 6 weeks (Fig. 4A e a, d).
Compared with model group 1, the amount of positive cells
within individual hepatic lobules was significantly increased
in statin group 1 and Chinese herb group 1 (FZ 9.093, P all
<0.001, Fig. 4B). In addition, increased positive cells were
observed mainly in the perilobular region in statin group 1
Figure 4 ABCA1 protein expression patterns in the liver. (A) Immunohistochemical staining of ABCA1 in liver tissue sections in
each group. Images a, b, c, g, h, i, and m demonstrate a representative hepatic lobule. The letter V refers to the central vein, and
the brown rings indicate the ABCA1-positive hepatocytes. Images d, e, f, j, k, l, and n (barsZ 50 mm) are the higher magnifications
of dotted boxes in images a, b, c, g, h, i, and m, respectively. (B) Evaluation of the percentage of ABCA1-positive hepatocytes in
one hepatic lobule among all groups. *P < 0.05, vs. model group 1; **P < 0.05, vs. model group 2; #P < 0.05, vs. statin group 2.
Tiaozhi Tongmai Granules 45(Fig. 4A e b, e) and in the whole hepatic lobule in Chinese
herb group 1 (Fig. 4A e c, f). However, the difference in
positive cell number between these two drug groups was
non-significant (P Z 0.075). The amount of positive cells
within individual hepatic lobules in model group 2 was
decreased significantly compared with model group 1
(P < 0.001), and such cells were hardly observed in the
perilobular region after 12 weeks (Fig. 4A e g, j). Statin
group 2 still displayed a perilobular distribution of positive
cells (Fig. 4A e h, k), whereas Chinese herb group 2
demonstrated an extensive distribution including the cen-
trilobular area near the CV (Fig. 4A e i, l). The positive cell
numbers in these two drug groups (P all <0.001) increased
significantly compared with model group 2, and the in-
crease rate was significantly higher in Chinese herb group 2
than in statin group 2 (P Z 0.001).Discussion
The results demonstrated that Tiaozhi Tongmai Granules,
which embody the TCM therapeutic principles of replen-
ishing qi, activating blood, strengthening spleen, and
resolving phlegm, can have an anti-atherogenic effect in
rabbits. Thus, the potential pharmacologic mechanisms by
which this therapeutic principle works will be the main
content discussed in this paper.
The spleen in TCM is primarily in charge of trans-
formation and transportation of grain or food, that is, the
spleen transforms grain into food essence and blood and
transports the body fluid for the stomach. This mechanism
of blood formation is described in various TCM classics as a
process in which the transformed food essence from grain is
discharged into the blood vessels, designated meridians or
46 Q. Sun et al.collaterals, and is further transformed into red blood,
which is refined essence, followed by circulation for the
nourishment of proximal and distal tissues, all via the
spleen. The actions of discharging and circulating are
actually an alternative embodiment of transportation.
Thus, the general pathway of “essence metabolism” in-
cludes the continuous processes of essence transformation
to transportation and from transportation to trans-
formation again. In addition, these processes are also the
ones that transfer from non-selective to selective essence
disposal in which essence is continuously subdivided into
components, such as cholesterol and other lipids, with
different functions. The refined essence within blood ves-
sels can be further utilized by the cells in the vascular wall,
transported within the cells, or removed from the cells
depending on cellular metabolic needs. This then is a multi-
level, step-by-step refined and microcosmic metabolic
pathway of essence, every level of which involves the
functioning of the spleen.
According to TCM theory, pathologically, the spleen is the
source of phlegm. If the spleen’s function is impaired, the
grain (food) is not completely transformed, and the un-
transformed portion converts into phlegm. Similarly, if the
ABCA1-mediated cholesterol efflux is impaired, large
amounts of cholesterol that is deposited within vascular
macrophages lead to an increasing number and size of
intracellular lipid droplets and eventually foam cell forma-
tion, thus threatening overall cellular lipid metabolism or
even energy homeostasis. The excess cholesterol accumu-
lated in macrophages loses its physiologic functions and
form the pathological substances required for the genera-
tion of atherosclerotic plaques. These substances resemble
those that have a thick and dense nature and stagnate in the
meridians, tissues, and viscera-phlegm as defined by TCM.
Actually, such lipid plaques are generally known as phlegm
by a number of TCM scholars.24,25,26 Thus, it is reasonable to
speculate that the dysfunction of ABCA1 in macrophages is
the determining factor for phlegm formation. ABCA1 in
macrophages plays a role that is very similar to the spleen in
TCM, and its function may be regarded as the same as that of
the spleen’s function. In addition, the up- and down-
regulation of ABCA1 protein expression level would repre-
sent the strength of the spleen’s function. It follows that the
abstract spleen at the macro level in TCM is microcosmically
subdivided into individual figurative vascular macrophage.
Therefore, if macrophages maintain an active cholesterol
efflux mediated by ABCA1, that is, maintaining the robust
TCM function of the spleen, cholesterol could be completely
transformed following ingestion by macrophages, just as Ji
Sheng Fang (prescriptions for succoring the sick)27
described, so that there is limited opportunity for them to
form phlegm, that is, lipid plaques. The present study ap-
pears to confirm our hypothesis that Chinese herbs function
by strengthening the spleen and resolving phlegm. The herbs
in Tiaozhi Tongmai Granules include raw Huangqi (Radix
Astragali), Juemingzi (Semen Cassiae), Zexie (Rhizoma
Alismatis) and raw Shanzha (Fructus Crataegi), which in
combination improve the function of ABCA1 in macrophages
by enhancing its protein expression at week 12 after vessel
injury.
It should be mentioned that under certain circumstances
simply resolving phlegm through improving the function ofviscera represented mainly by the spleen while ignoring the
adjustment of the material basis of visceral functional
activitiesdqi and bloodddoes not work. The TCM classic,
Su Wen Tiao Jing Lun (Plain Questions Treatise on Modu-
lating Meridians),28 described that viscera are connected
to each other and to other parts of the body by meridians
that circulate qi and blood. Thus, there is a close rela-
tionship between the condition of qi and blood and the
function of viscera. In addition, qi and blood may be the
first to undergo disorder when diseases occur in which case
the disharmony of qi and blood becomes the premise
behind the dysfunction of viscera. Thus, only when qi and
blood are in harmony will the viscera be fully functional
such that the function of the spleen is robust so that
phlegm has no chance to be generated.
ApoA-I, a major protein component of high density li-
poprotein in plasma, is produced by the liver3 and circu-
lates to peripheral tissues such as vascular walls.
Interaction of lipid-poor apoA-I with the ABCA1 molecules
of macrophages promotes phosphorylation of ABCA1 pro-
tein, boosting its kinase activities and enhancing its sta-
bility29,30 via a variety of signaling pathways, including
PCPLC-DG-PKC,31,32 AC-cAMP-PKA33,34 and RhoA GTPase35
as well and thus maximizing the potential of ABCA1 func-
tionally. However, failing to be lipidated, lipid-poor apoA-I
suffers a rapid catabolism once produced.3 Fortunately, the
hepatocellular ABCA1 mediates the initial lipidation of
apoA-I.36 Harboring a larger hepatocytes base than macro-
phages, the liver is the organ that expresses the most
ABCA1 proteins. Such large amounts of ABCA1 in hepato-
cytes aid apoA-I in achieving the fullest potential of ABCA1
in peripheral macrophages functionally, just as the har-
mony of qi and blood helps mobilize the full potential of the
spleen’s function in macrophages. The protein expression
of the functional ABCA1 in hepatocytes plays a unique role
that is, to some extent, the equivalent of the harmony of qi
and blood.
To enhance protein expression of hepatocellular
ABCA1, qi and blood need to be harmonized. For this
reason ingredients that replenish qi and activate blood in
Tiaozhi Tongmai Granule, including raw Huangqi (Radix
Astragali), Danggui (Radix Angelicae Sinensis), Dilong
(Lumbricus) and Sanqi powder (Radix Notoginseng), are
used. In our study, this formula was found to improve
hepatocellular expression of ABCA1 at weeks 6 and 12,
setting the stage for mobilizing the spleen functionality in
macrophages.
Chinese herbs appear to play a lipid-lowering effect in
the early lesion stage. With increasing duration of treat-
ment, this effect was more significant although milder than
that observed with atorvastatin. The atherosclerotic lesions
of the CCA were mild in the early stage and became
advanced in the later stage, whereas the lesions of the TA
in the later stage were still mild and not yet comparable to
those of the CCA in the early stage. The therapeutic effects
of Chinese herbs and statin for reducing atherogenesis and
up-regulating ABCA1 protein expression in vascular macro-
phages were not prominent for the mild lesions of the CCA
in the early stage; only atorvastatin reduced the maximal
intimal thickness percentage. When the advanced lesions of
the CCA formed in the later stage, these effects were sig-
nificant, and Chinese herbs played a more marked role in
Tiaozhi Tongmai Granules 47lowering the maximal intimal thickness percentage. As this
percentage represents the degree of plaque eccentricity,
the results indicated that atorvastatin reduced the degree
of plaque eccentricity of mild lesions, whereas Chinese
herbs diminished that of advanced lesions more obviously.
For the mild lesions of the TA in the later stage, the effect
of reducing atherogenesis was not fully achieved, whereas
the up-regulation of ABCA1 protein expression in macro-
phages was significant. Thus, the effect of Chinese herbs in
reducing atherogenesis may be more related to lesion
severity than to lesion stage, and up-regulation of ABCA1
protein expression in macrophages may be more correlated
with duration of drug intervention than to the lesion
severity.
In the liver, ABCA1 protein expression was activated
and up-regulated during the early development stage of
atherosclerotic lesions and further enhanced by Chinese
herbs and atorvastatin. In the later development stage of
lesions, a relatively high level of ABCA1 protein expression
was maintained, with Chinese herbs displaying a more
significant advantage than atorvastatin. These results
suggested that ABCA1 protein in hepatocytes might be
more sensitive to the up-regulating effect of drugs
compared with vascular macrophages, which thus ac-
counts for the occurrence of their early therapeutic
effect.
In sum, though in the short-term, Chinese herbal ther-
apy may fail to present marked improvement of mild
atherosclerotic lesions, it may be sensible not to underes-
timate the power of gradual and quantitative changes and
abandon treatment, as reflected in the old saying that good
things come to those who wait. Thus, the results from our
study indicate that sustained administration of Tiaozhi
Tongmai Granules may produce significant therapeutic
effects.
Conclusion
The herbs in Tiaozhi Tongmai Granules, a compound that
embodies the therapeutic principle of strengthening the
spleen and resolving phlegm, work synergistically by
replenishing qi and activating blood and improve the
function of the spleen in vascular macrophages via the
hepatocyte ABCA1/macrophage ABCA1 pathway, thereby
producing an anti-atherogenic effect derived from the
sustained application of the medication.
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